Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-13, Stock:LLY, The news for the past five days is as follows:
2021-12-06: NEWS1: AbbVie (ABBV) Adds FDA-Issued New Warnings to Rinvoq's Label.NEWS2: Lilly (LLY) COVID-19 Antibody Gets FDA Nod for Use in Kids.
2021-12-07: NEWS1: Here is What Hedge Funds Think About Eli Lilly and Company (LLY).NEWS2: 10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors.NEWS3: Biohaven (BHVN) Intranasal Migraine Therapy Meets Goal in Study.NEWS4: Roche (RHHBY) Actemra Gets CHMP Recommendation for COVID-19.
2021-12-08: NEWS1: Eli Lilly's Pipeline Strength Paints a Promising Outlook.NEWS2: UPDATE 2-China approves Brii Biosciences antibody COVID treatment.
2021-12-09: NEWS1: AstraZeneca (AZN) Gets FDA Nod for COVID Prevention Drug.NEWS2: New Lilly Study Reveals Underappreciation of Bowel Urgency as a Symptom of Ulcerative Colitis and Highlights Communication Gap Between Healthcare Providers and Patients.
2021-12-10: NEWS1: UPDATE 2-Drugmakers aim big price hikes at U.S. patients, congressional report finds.NEWS2: Eli Lilly Pens $1.5B Pact With Regor For Metabolic Disease Therapies.NEWS3: Drugmakers aim big price hikes at U.S. patients, congressional report finds.NEWS4: Drugmakers aim big price hikes at U.S. patients -congressional report.NEWS5: Pharma Stock Roundup: PFE Booster Works on Omicron, AZN COVID Cocktail Gets FDA Nod.NEWS6: Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders.

Answer: Rise